The webinars, which are free of charge, are:
The webinars join 'The gastrointestinal microbiome and its effects', which is already available for free viewing via The Webinar Vet.
Product Manager Kai Crawshaw said: “We’ve received excellent feedback on the webinars from those who have already viewed them through our Learning Alliance platform. We hope that by also making them available via The Webinar Vet, we will make them more easily accessible to a higher number of veterinary professionals keen to refresh their knowledge in these important areas.”
The Animalcare webinars can be viewed here: https://www.thewebinarvet.com/webinars/animalcare
The Association says it delayed this decision as late as possible, and whilst the most recent government advice does not prohibit large public gatherings, it recognises the importance of personal safety for Congress attendees and the need to support the profession in preserving business continuity, maintaining client services and protecting animal welfare.
Amanda Stranack, BSAVA CEO, said: "As the situation continues to escalate, the government have given a clear steer that they expect more stringent controls to come into force in the coming weeks. With Congress now only a few weeks away, we want to give all our attendees as much notice as possible, both to ensure peace of mind, and to give people adequate time and flexibility to change their plans.
"BSAVA recognises the pressures the current situation brings to bear on the veterinary community and in making this difficult decision, has the interests of the profession first and foremost in its mind.
"We would thank all those who have worked hard over the past two years to contribute to the development of Congress, a huge amount of effort goes into preparations from BSAVA volunteers, Congress participants and our staff."
Sue Paterson, BSAVA President, said: "It is with great regret that we have made the difficult decision to cancel Congress, which has taken place annually for more than 60 years. Congress is an incredibly important event in the veterinary calendar, and we were all looking forward to an inspiring agenda and saying a fond farewell to the city that has made Congress such a great success over so many years. The health and wellbeing of our attendees is of utmost importance to us, and whilst we are sorry to be making this decision, we are confident it is the right one."
BSAVA says it is aware of the impact that cancelling will have on many delegates' CPD hours, so it is now looking at other ways it can deliver Congress lectures and podcasts.
Sue added: "Whilst we won’t be able to deliver the full Congress programme, we will be working with our speakers to capture as many lectures as we can to make content available online."
When you post a job advert, or a shout for assistance on VetNurse Jobs, it is emailed to subscribers immediately and fed out onto other social networks. You can further extend the reach of your post by sharing it yourself and (with "Share and reward") encouraging other members of your team to do likewise.
I have taken the decision to drop the charge for advertising because it seems very clear now that we all face a very grim few months ahead, and it has never been more important that we all pull together and support each other, both personally and in business.
Of course, removing the charge for advertising for help on VetNurse.co.uk and VetSurgeon.org is not, in and of itself, going to save anyone from going under, but I hope perhaps other veterinary suppliers might follow my lead and consider dropping their prices until such time as everyone is back on their feet.
Over the last few months, VetNurse.co.uk has been undergoing a major upgrade, and we're now within two weeks relaunching the website. When we do, I have a number of other ideas in the pipeline, all designed to help bring the profession together and support each other, which I will announce shortly thereafter.
Meantime, take care everyone.
Ceva says the course is aimed at vets and nurses who want to build their confidence and take the lead in finding hypertension in cats in their clinic.
The course is hosted by Sarah Caney BVSc DSAM(Feline) MRCVS, one of the UK's leading specialists in feline medicine, and will cover things like finding out which cats need screening for feline hypertension, how to become confident in recommending a blood pressure check to owners, hints and tips on taking a reliable blood pressure measurement and handling cats calmly to reduce ‘situational hypertension’.
The course consists of four 30-minute recorded sessions including course notes and self-assessment questions for each module. Once completed, the delegate will receive a Hypertension Ambassador pin badge and a certificate for four hours’ CPD. The first 500 delegates to complete the course will be offered either a cat hide or an eye atlas.
The course can be completed online at any time. There are also weekly feline hypertension live sessions at 1pm, from Wednesday 4th March until Wednesday 25th March. They offer the opportunity for you to ask questions, but they're also recorded so you can watch them any time thereafter.
Suzanne Page BVSc MRCVS, cardio-nephrology-hypertension product manager at Ceva Animal Health, said: "Our HypertensionAmbassadors’ initiative will educate veterinary professionals on every aspect of feline hypertension to enable them to confidently talk to their clients about the condition, measure blood pressure in a cat-friendly way and offer advice on the different treatments available."
For more information, and to register, visit www.veterinarywebinars.com/feline-hypertension-ambassador.
Procanicare contains three live strains of canine-specific Lactobacillus bacteria, which, according to the company, make it an ideal GI support product to maintain balance in the GI intestinal microbiome of dogs, particularly when an alteration to the intestinal microbiome is a risk.
Animalcare says studies show that the strains of Lactobacillus found in Procanicare have been shown to promote indigenous intestinal commensal populations, reduce numbers of potentially pathogenic bacteria and improve stool consistency.1,2
Dr Shea Beasley, Product Development Manager at Vetcare Ltd said: "The strains of Lactobacillus found in Procanicare have been commercially available in Scandinavia for two years now. It has achieved great success, with Scandinavian vets frequently recommending it in situations where the gastrointestinal microbiota can become unstable such as following antibiotic use and in stressful situations such as travelling and kennelling, as well as when supporting the intestinal microbiome is particularly important, such as during pregnancy and lactation."
Available exclusively through vets, Animalcare has produced a range of waiting room materials to help you educate about and promote Procanicare in practice, including a poster, bunting, leaflet and leaflet holder.
There is also a free webinar for veterinary professionals on the importance of the intestinal microbiome, available to view at www.thewebinarvet.com/webinar/the-gastrointestinal-microbiome-and-its-effects.
To find out more or to try Procanicare in your practice, contact your local Animalcare representative via email animalcare@animalcare.co.uk or telephone 01904 487687 or visit www.procanicare.com.
References
The chewable, prescription-only tablet contains sarolaner, which kills fleas and ticks; moxidectin, for the prevention of heartworm, lungworm disease and for the treatment of some intestinal worms; and pyrantel embonate, for the treatment of gastrointestinal nematodes (hookworms and roundworms).
Professor Tim Geary, BSc PhD, Professor Emeritus, Institute of Parasitology, McGill University, Canada, and Professor, School of Biological Sciences, Queen’s University, Belfast, a consultant to Zoetis, said: “Serious diseases that are preventable and of increasing prevalence threaten dogs in Canada and Europe. Simparica Trio today offers a better solution to preventing and controlling these parasites against the concern of their increasing prevalence."
Rob Kelly, President, International Operations at Zoetis said: "With Simparica Trio, we bring to market an advanced parasiticide solution, helping to deliver improved client satisfaction and patient protection.
"Thanks to its broad spectrum, Simparica Trio helps veterinarians and dog owners provide more complete parasite coverage with a single-monthly chewable tablet. The broad spectrum of Simparica Trio minimises the potential risk of parasite protection gaps."
Simparica Trio is indicated for dogs from at least eight weeks of age and 1.25 kg and will be available in six tablet strengths for dogs of all sizes.
For more information about Simparica Trio and full prescribing information, visit www.zoetis.com.
The Committee had found Dr Elefterescu guilty of serious professional misconduct in relation to a number of charges which covered issues such as dishonesty, poor record-keeping, and failure to carry out adequate clinical examinations.
The full charges and findings of the RCVS Disciplinary Committee can be found at: www.rcvs.org.uk/disciplinary.
The Judicial Committee of the Privy Council held the appeal hearing in October last year with three Justices of the Supreme Court - Lord Kerr, Lord Carnwath and Lord Kitchin – comprising the Board.
The basis of the appeal to the Privy Council was that the Committee’s findings on the facts of the case were flawed, with his counsel saying that Dr Elefterescu 'strenuously disputes the findings by the Committee of his dishonesty and lack of professional competence and submits that there is no adequate basis for them in the evidence’.
His counsel also told the Board that the Disciplinary Committee’s sanction failed to take into account mitigating factors and that the decision to remove Dr Elefterescu from the Register was disproportionate.
In relation to the appeal against the Disciplinary Committee’s findings on the facts, the Board was not persuaded by any of the arguments put forward on behalf of Dr Elefterescu. These arguments included that the RCVS had failed to call relevant witnesses and had failed to make Dr Elefterescu aware of the significance of some evidential matters, disclosed to him.
In respect of the sanction, the Board was also unpersuaded by the arguments put forward by Dr Elefterescu’s counsel, namely that it was too harsh in its assessment of aggravating factors, did not give adequate weight to mitigating factors, and that it failed to distinguish lack of competence from misconduct.
In its judgment on the arguments put forward by Dr Elefterescu’s counsel, the Board said: "It is the opinion of the Board that these criticisms are not well founded. The Committee considered with care Dr Elefterescu’s proven and admitted conduct in relation to each of the charges and whether it fell below or far below the standard to be expected. It is to be noted in this regard that a number of the charges which were either admitted or upheld were not the subject of any challenge on this appeal.
"Overall, the Committee found that Dr Elefterescu’s clinical failures were very serious, involved failures in the basics of animal care, resulted in animal suffering and involved widespread breaches of the respondent’s [RCVS] code of professional conduct. It also expressed particular concern about its findings of dishonesty, and rightly so. That conduct was, in its view, ‘at the top end’ of disgraceful conduct in a professional respect. What is more, Dr Elefterescu had a lack of insight into his failings and a wholly unjustified confidence in his abilities which constituted an ongoing risk to animal welfare."
"These were findings which the Committee was clearly entitled to make and, in the light of them, the Board is firmly of the view that the decision of the Committee to direct the removal of Dr Elefterescu’s name from the Register cannot be impeached. The Board rejects the criticisms made of the Committee’s reasoning and the conclusions to which it came. The direction that Dr Elefterescu’s name must be removed from the Register was appropriate and proportionate."
The Judicial Committee’s full findings can be found at www.jcpc.uk/cases/docs/jcpc-2018-0060-judgment.pdf.
Speakers at the event will include Andrew Sparkes, BVetMed, PhD, DipECVIM, MANZCVS, MRCVS (pictured right) and Ebenezer Satyaraj, PhD.
BSAVA Congress delegates can register for the free symposium, which also includes lunch, at www.tickettailor.com/events/purina/349478.
Libby Sheridan, MVB MRCVS, Purina Veterinary Technical Affairs Manager, said: "Veterinary professionals often see the consequences of sensitivities to cat allergens - which for some, it may even mean relinquishment of the pet with all the emotion attached around that event. This symposium will focus on the consequences for cat welfare and how the profession can help support their cat-owning clients through a breakthrough approach."
The new approach is based on neutralising the major cat allergen in cats' saliva, Fel d 1, through feeding a cat food coated with an egg product ingredient containing anti-Fel d 1 antibodies.
This, says the company, helps to reduce the active allergen transferred to hair and dander during grooming, and ultimately helps reduce active Fel d 1 in the environment.
Dr Sparkes is a diplomate of the European College of Veterinary Internal Medicine and the founding and current co-editor of the Journal of Feline Medicine and Surgery, the official journal of ISFM and the American Association of Feline Practitioners. He will be sharing his review of the literature around feline relinquishment.
Dr. Satyaraj is a member of the American Association of Immunologists and the American Veterinary Immunology Association and a reviewer for several journals including the British Journal of Nutrition and Arthritis & Rheumatism. He is also a Fellow of the Academy of Science in St Louis and a leading scientist at the Purina Institute. Dr Satyaraj will be focusing on the studies supporting this important area of research.
The symposium provides 1.5 hours of certified CPD. More information about the science is available at www.purinainstitute.com.
Neptra contains florfenicol, an antibiotic which Bayer says is ideal for dealing with the Staphylococcus pseudintermedius found in the majority of otitis externa cases, together with terbinafine hydrochloride, which is effective against Malassezia pachydermatis, and mometasone furoate, a corticosteroid that provides anti-inflammatory activity to improve patient comfort.
A single, 1ml dose in each affected ear treats dogs of all breeds and in trials, continuous clinical improvement was seen until day 28.
Neptra was approved for use in the USA back in 2015, where it has apparently gone down a bit of a storm, becoming the number one product for otitis externa in the country, with over 4.7 million doses prescribed since 2017.
Dr Ken Kwochka, DVM, DACVD, President of the World Association for Veterinary Dermatology (pictured right) said: "This solution is trusted by thousands of vets across the USA, it’s now time for UK vets to benefit from the convenience and confidence Neptra offers. Neptra is the ideal and easier way to treat the majority of otitis externa cases you see and can (and should) be used first-line."
Donna Tomlinson, Senior Brand Manager at Bayer said: "It’s not every day that you’re able to launch a solution that has the potential of Neptra to change treatment practices for the better and improve outcomes for dogs. Across the UK and Europe, our brilliant team at Bayer have put months of effort into this launch and developed an exciting marketing support package. Our veterinary business managers are already out on the road, ready to talk to you all about it."
Neptra is available now to order as one SKU via your regular wholesaler or speak to your Bayer veterinary business manager.
Practice support materials are also available via www.vetcentre.bayer.co.uk.
The app allows trainers to store and share medical records and treatment plans, identify horses and, with a Bio Thermo chip, monitor temperature non-invasively.
In Ireland, the Irish Horse Racing Board (IHRB) requires every yard keep a Blue Book which has to be submitted monthly. In the Blue Book, every medication given to every horse is recorded, with the amounts, the name of the medication and its batch number all written in by hand. EquiTrace enables a trainer to email the blue book information direct from their mobile phone.
Vincent O’Connor, senior vet at Sycamore Lodge Equine Hospital on the Curragh, Ireland, says he has found the app very easy to use and particularly appreciates the way it suggests stand down periods required for intraarticular medication, where injections into different joints require different numbers of days withdrawal before competition. The experience of John Oxx, whose winner I Know I Can was disqualified because of a positive test for TCA (triamcinolone acetonide) on 2 July 2020, is a case in point. Dr Lynn Hillyer, IHRB Chief Veterinary Officer and Head of Anti-Doping, stated that the minimum recommended stand down time for TCA would be 14 days but added that the stifle is a complex joint and can be associated with longer excretion times than might be expected.
Kevin Corley said: "Keeping a horse’s identity straight might seem a simple thing, but when you have a yard where staff and horses can change frequently and records are kept in the office, far away from the stables and fields where the horses are, it is not as easy as you think. I remember a time when I was called out to genetically test four two year olds, each valued at over €50,000 because their registration documents had been lost before they had been filed and no one knew which one was which."
EquiTrace has been in trials in Ireland, England, USA, Sweden and Italy and Kevin says every yard which has tested the app has kept it in operation.
EquiTrace is a subscription service, with a basic service for $1/€1 per month per horse and a premium subscription at $2/€2 per month per horse. A scanner available from EquiTrace as a one-time cost is required to operate the system, ranging in price from €250 to €400 or USA $350 to $550.
EquiTrace works with all ISO-compliant microchips but some of the service offerings are dependent on the type of chip in the horse.
EquiTrace is available on Apple and Google appstores. Establishments with over 200 horses can contact EquiTrace directly to arrange a subscription. Current clients include DK Weld in Ireland, Ramsey Farm and Three Chimneys Farm in Kentucky, USA, Kinsale Stud in the UK and Avantea in Italy.
For more information, visit: https://equitrace.app
Dan, who is a novice runner, will be running the 13.1 miles between Newcastle and South Shields on Sunday 12 September. He said: “You’d think that lockdown would be the perfect opportunity to train hard and then breeze through the ‘world’s biggest and best half marathon’ but, perhaps like many others, I ate cheese and drank wine for 18 months, so the challenge is now really on.
“I’m raising funds to help save the rhino because the conservation of these magnificent animals is so important and I hope the added pressure of supporting the charity will propel me across the finish line. I’m also excited to be running in Newcastle at a time when Medivet is growing its presence in the North-East of England.
“Running in the rhino suit will be tough but it has an internal fan which I hope will keep me cool on the day. Let’s hope the weather will be kind!”
Donations to support Dan's fundraising can be made at https://uk.virginmoneygiving.com/DanSutcliffe1
Matthew's address looked at the significance of 2021 as veterinary nursing’s Diamond Jubilee – representing 60 years since the first RCVS-approved Auxiliary Nursing Assistant course.
He spoke about how this was likely to be a year of firsts for the profession, including the awarding of the first Certificates in Advanced Veterinary Nursing, the recruitment of the first VN Practice Standards Scheme Assessors and the first time there would be 20,000 veterinary nurses on the RCVS Register.
He also spoke about the planned activities to celebrate the Diamond Jubilee including webinars, podcasts and the publication of an eBook about the history of the profession.
Matt said: “For my own first podcast I interviewed Jean Turner who – I don’t think she’ll mind me saying – has been a member of the profession for a good chunk of the last 60 years.
“She’s a real professional hero of mine and I had a fascinating conversation with her about what has changed, what hasn’t changed and what really needs to change!
“Speaking to Jean reminded me that we all stand on the shoulders of giants. Where we are as a profession is down to those who came before us and we owe it to them, and future generations of veterinary nurses, to make sure we are always progressing and improving.”
Matt said that with RCVS Council’s adoption of the proposals for legislative reform in June this year, the veterinary nursing profession had a bright future ahead of it, with protection of title and a bolstered role in areas such as anaesthesia being included in any future legislation.
“I still sometimes hear my veterinary nursing colleagues refer to themselves as ‘just a veterinary nurse’. Whenever I hear it said, I challenge it.
“With the Diamond Jubilee celebrations this year I think we will be making a very big challenge to that mindset, and it will remind all veterinary nurses that we are brilliant professionals, with a long and proud history and that we are a force for good in society.”
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
The Disciplinary Committee heard that in 2018, when Dr Dyson was employed as Head of Clinical Orthopaedics at the Animal Health Trust (AHT), she completed a research project: ‘Influence of rider: horse body weight ratios on equine welfare and performance – a pilot study’, for which she had previously been given the go-ahead by the AHT’s Clinical Research Ethics Committee. The results of the study were then submitted to the Journal of Veterinary Behaviour: Clinical Applications and Research for publication.
After peer-reviewing the project paper at the request of Journal Editor Karen Overall, Dr Matthew Parker, a Senior Lecturer in Behavioural Pharmacology at the University of Portsmouth, was concerned by the lack of a Home Office licence and asked for details of the licence or an explanation of why the project didn’t need one, and for the paper to be re-submitted.
In reply, Dr Dyson then emailed Ms Overall saying: “We have a former Home Office Inspector on our AHT Ethical Committee and two current licence holders (Named Veterinary Surgeons) who are fully conversant with the current legislation ... I also sought informal advice from a current Inspector. All were fully aware of the protocols to be employed and gave me assurance that in their opinion Home Office approval would not be required”.
Ms Overall then asked Dr Dyson to obtain a letter from the Home Office to support this position.
On 24 December 2018, Dr Dyson sent Ms Overall a letter purportedly from a Home Office Inspector called Dr Butler who, she explained, had advised her during the planning phase of the project. In the letter, the fictitious Dr Butler confirmed that their advice was sought for the project and that in their opinion, a Home Office Licence was not required.
Ms Overall then sent the letter to Dr Parker for further review, who decided to contact Dr Martin Whiting, Head of Operations at the Home Office Animals in Science Regulation Unit (ASRU) to ask if he knew of Dr Butler.
Dr Whiting confirmed that the Home Office had no record of employing a Dr Butler as an Inspector and that they were in the process of making further inquiries into the matter.
After Dr Whiting’s reply was forwarded to Dr Dyson, she replied to him saying that she thought the studies’ procedures did not meet the criteria for the Animals (Scientific Procedures) Act 1986 (ASPA), but that this was questioned by peer reviewers.
She said that her decision to send Dr Butler’s letter was one that she would ‘eternally regret’ and that she was ‘an inherently honest person’.
She explained that she was under a huge amount of pressure in her personal and professional life and that she was ‘fully aware that [she] acted completely inappropriately and she requested the incident be overlooked’.
In March 2019, Dr Dyson sent a letter to William Reynolds, Head of the Home Office ASRU, in which she expressed remorse for writing the letter. Mr Reynolds subsequently raised a concern with the RCVS about Dr Dyson’s alleged behaviour.
Dr Jane Downes, who chaired the Disciplinary Committee, and spoke on its behalf, said: “The Committee heard from Dr Dyson that she had no recollection of several events detailed in the charge, including writing the letter from Dr Butler and sending the email to Ms Overall which contained Dr Butler’s letter. She accepted that the letter was dishonest and that it should not have been sent. However, she also claimed that, as she could not remember writing the letter, she did not act dishonestly.
The Committee heard testimonials from several witnesses who held Dr Dyson in high regard, including colleagues from the AHT, who attested to her integrity.
However, there were many dubious claims made by Dr Dyson throughout the hearing, including that the Home Office Inspector that she referenced as ‘my friendly inspector’ was someone who could have given informed consent to a project as Dr Dyson confirmed that she had met the individual briefly, around two and a half years ago at a drinks reception.
In reaching its decisions, the Committee considered Dr Dyson’s previously impeccable character, the written and verbal testimonies from witnesses. They also considered that during the hearing, Dr Dyson explained that at the time she fabricated the letter, she was under a lot of work and personal pressures, including managing a workload amidst colleagues’ resigning or going on maternity leave and it being the anniversary of her dog having to be humanely destroyed.
However, it did not accept Dr Dyson’s claims that she had amnesia at this time, and considered that she had not owned up to her wrongdoing until it was discovered. Although Dr Dyson maintained her actions were not pre-meditated, the Committee considered that, in the case of the forged letter, a certain amount of planning and careful thought was involved. The Committee believed that Dr Dyson knew what she was doing at the time, but acknowledged she may subsequently have blanked out what she did.
The Committee found all but one of the allegations proved and confirmed that it “was satisfied that the writing and sending of that letter was the culmination of a course of dishonest conduct.”
Committee Chair Dr Downes said: “In assessing [the evidence of] Dr Dyson the Committee took into account the difficulty faced by any Respondent appearing before their Regulator and also the various interruptions occasioned by issues which had to be dealt with during her evidence. Whilst [Dr Dyson is] undoubtedly highly qualified and highly respected, the Committee nevertheless considered her evidence lacked credibility and was not reliable.”
The Committee found that Dr Dyson’s conduct had breached parts of the RCVS Code of Professional Conduct for Veterinary Surgeons and amounted to serious professional misconduct.
Dr Downes continued: “The Committee determined that it was important that a clear message be sent that this sort of behaviour is wholly inappropriate and [was] not to be tolerated. It brings discredit upon Dr Dyson and discredit upon the profession.
"For whatever reason, Dr Dyson chose not to respond to Ms Overall’s email on 30th November 2018 in an honest and straightforward way. Instead, she lied about the makeup of the AHT Ethical Committee in order to cloak her response with authority.
"She also lied about having received advice from a current Inspector for the same reason. In the Committee’s view, she made a conscious decision to provide a dishonest response. She no doubt believed that would be the end of the matter.
"When that did not work, she lied further in the email to her co-author, Andrew Hemmings, claiming to have a letter from her friendly Inspector. When that too did not work, she impersonated a Home Office Inspector in creating the ‘Dr Butler letter’.
"She then added a false declaration to the manuscript, which she subsequently submitted to the Journal along with an email containing yet further lies. That was all done in a blatant and wilful attempt to deceive Ms Overall ... into believing the contents of the correspondence to be true, that confirmation a Home Office Licence was not required had been obtained and all was therefore well with the submitted manuscript.
"There was no rush, or urgency to have the paper published and the actions were not done in a moment of panic. No doubt she had not planned the entire course of events in advance, but instead reacted to each new obstacle that came her way, but her overall course of dishonest conduct spanned over three weeks.
“The Committee was well aware of the impact and ramifications for Dr Dyson of any decision to remove her from the Register but had to weigh her interests with those of the public.
"In doing so it took account of the context and circumstances of the case, all matters of personal mitigation, as detailed above, Dr Dyson’s undoubted distinguished international career and reputation and the need to act proportionally.
"However, for all the reasons given above, the Committee was of the view that the need to uphold proper standards of conduct within the veterinary profession, together with the public interest in maintaining confidence in the profession of veterinary surgeons, meant that a period of suspension would not be sufficient and that the only appropriate and proportionate sanction in all the circumstances of this case was that of removal from the Register."
Vetbromide is presented as a 600mg double divisible tablet for both large and small dogs, and for greater flexibility with dose titration. Tablets are blister packed for ease of storage and dispensing, with a four-year unopened shelf life.
Alongside the launch, TVM has prepared a range of product support materials, including: product guidelines, treatment and monitoring guidelines, seizure management ‘lunch and learn’ sessions, and pet owner information.
TVM has also created a free e-learning tool which takes veterinary staff through the process of diagnosing, treating and monitoring dogs with suspected epilepsy.
Will Peel, product manager at TVM said: "The addition of Vetbromide to our epilepsy range allows vets more flexibility when treating epileptic patients. To further assist vets, we are also offering a wide range of free literature and in-practice support to ensure that veterinary staff are up to speed on such a common, yet at times complicated, topic.’
For more information, visit www.tvm-uk.com/epilepsy, or contact your TVM UK Territory Manager.
The statistic came to light as a result of Ceva's Mercury Challenge1, in which veterinary practices from around Europe took blood pressure readings from over 10,000 cats over seven years old, 4000 of which were from the UK.
The Challenge results, which were recently presented at Ceva Cat Expertise 2021 by the international feline medicine specialist, Dr Andy Sparkes, showed that more than 40% of cats enrolled in the Mercury Challenge were hypertensive, with a blood pressure about 30% higher than the blood pressure value found in healthy cats.
Ceva says this high percentage suggests that feline hypertension may be even more common than suspected, especially in the ageing cat population, with the mean age of hypertensive cats found to be 13 years old in the Challenge.
The study also found that up to one in three cats had both hypertension and chronic kidney disease (CKD). Feline hypertension is also associated with hyperthyroidism.
Jodie Tanner, veterinary surgeon at Lime Tree Vets in Staffordshire who participated in the Mercury Challenge said: “We were surprised by how many of the cats whose blood pressure we measured as part of the Mercury Challenge were actually hypertensive and were taken aback at the number of hypertensive cats which lacked clinical signs or target organ damage.
"These hypertensive cats would have previously gone undetected prior to us screening our older patients and they would probably have only presented when they had advanced target organ damage, such as blindness.
“Measuring blood pressure in cats is now incorporated into our bespoke preventative health care plan – The Pet Plus Membership – and our ‘Gold Plan’ is tailored to our patients over eight years of age.
"Included in the Gold Plan are twice yearly blood pressure checks, so we can pick up hypertension cases as early as possible, and the plan also includes twice yearly urine screens and yearly blood screens to pick up other common diseases seen in older cats such as hyperthyroidism and CKD.”
Ceva has a range of resources available to support veterinary practices, including those that want to set up vet nurse blood pressure clinics. There's a digital hypertension tool kit available by registering at www.easethepressure.co.uk, where you will also find information on the Hypertension CPD Hub, an Ease the Pressure pack containing resources to support vet practices, owner communications materials and information about Ceva’s online Hypertension Ambassador CPD course. A vet practice social media pack is also available.
For further information, visit www.easethepressure.co.uk or contact your local Ceva territory manager.
Reference
The association began to produce client information leaflets in 2011, to help its members provide information to clients about the safe use of the drugs that they prescribe and dispense for the patients under their care. Over the years the range of leaflet groups has expanded to include canine and feline behaviour and exotic pets, as well as medicines.
Designed to be printed easily in practice, all the leaflets have the option to add practice details if required. The new additions for June are Antihistamines, Ferrous sulphate, Fluconazole, Hydrochlorothiazide, Imipramine, Leflunomide, Travoprost and Trimethoprim/Sulphonamide, with authors including Polly Frowde, Hannah Hodgkiss-Geere, and Fergus Allerton.
Julian Hoad, Chair of the Publications Committee said: “We are proud to have hit this impressive milestone; we know that our client information leaflets are of great use to our members to help them keep their clients informed and we aim to add to this number every year.”
The client information leaflets are provided to BSAVA members as part of their member benefits and are also available for non-members to buy as part of the ‘Formulary Plus’ online subscription. You can find them in the BSAVA Library here.
The updated standards document applies to the awarding organisations and higher education institutions that set the veterinary nursing curricula, the centres (such as further education colleges) that deliver the courses, and the affiliated RCVS-approved training practices where SVNs undertake their placements.
The updated standards were approved by RCVS Veterinary Nurses (VN) Council in February 2021 after feedback from stakeholders.
There are six overarching standards within the framework, which also provide guidance on how the individual standards can be evidenced. The overarching standards are: learning culture; governance and quality; student empowerment; educators and assessors; curricula and assessment; and effective clinical learning.
The College says the new Standards Framework, which draws together all the previous separate guidance for awarding organisations, centres and training practices, allows greater flexibility for how training can be delivered.
Julie Dugmore, RCVS Director of Veterinary Nursing, said: “During 2020, accreditations and quality monitoring audits were conducted against the RCVS Standards Framework for Veterinary Nurse Education and Training. Feedback from all involved was positive but reflected a need for clarification in some areas and further examples to assist with evidencing compliance.
“Since February 2021, four accreditations have been conducted against the updated standards, the results of which demonstrate a positive move towards the outcomes based approach to accreditation and quality monitoring.”
The full set of standards can be read online at www.rcvs.org.uk/standards-framework-vn.
On day one, Laura Playforth, IVC Evidensia’s Group Quality Improvement Director, will be looking at psychological safety and the adoption of a safety-critical culture in veterinary practice.
Sayaka Okushima from Pride Veterinary Referrals and Sarah Heath, IVC's Director of Sustainability, will be discussing the use of anaesthetic gases and ways to reduce them.
Other talks on day one will include: ‘Vets vs Nurses: Are we Blurring the Lines?’ and ‘The Criminal Underworld and Animal Welfare’.
On the second day, IVC referral clinicians will present lectures on various subjects, from handling emergency situations to mastering diagnostic testing equipment in first opinion practice.
David Owen, a Referral ECC Clinician at Vets Now in Manchester, will be talking about talking about emergency dyspnoea cases and how veterinary colleagues can cope with challenging situations efficiently.
Frances Bird, a European Specialist in Small Animal Surgery at Pride Veterinary Referrals, will be closing out the day with a discussion on treating respiratory disease from a surgeon’s perspective.
For the full programme, visit: https://london.vetshow.com/conference-programme?&filters.LOCATION=63903&searchgroup=ADD5CDE8-conference-programme-2023
Topics covered will include practical applications of enrichment for zoo species, options for reproductive control in pet ferrets, challenges of exotics out-of-hours care, veterinary care of invertebrates and decision-making in wildlife cases.
The Association says that this year, there will be a greater focus on masterclasses, practical sessions and roundtable discussions, and that there will be plenty of new research, case reports, case series and the most recent advancements in the field of zoo, wildlife and exotic animal medicine.
There will be dedicated streams covering zoo health, nursing, exotic pets and wildlife health, together with a stream for students and new graduates.
The social programme includes the student-mentor mixer, a new vet nurse mixer, a wine and canapés evening, a gala dinner and silent disco.
Registration fees have been held at the same level as 2019: vet nurse tickets for non-members range from £185 for one day, to £265 for all three; members get a discount.
www.bvzs.co.uk
First, the practice carried out an infection control audit to ensure its protocols were robust.
The audit covered the cleaning of clinical areas, non-clinical areas (including offices, reception desks, kltchens and bathrooms), and the personal hygiene of staff members (including hand hygiene and work wear).
Using using the Nationwide Laboratory practice cleanliness screening programme, Rosemullion then conducted environmental swabbing of 10 clinical and non-clinical areas around the practice, including theatre tables, kennels, telephones and door handles, to review contamination levels.
Results showed varying levels of bacterial contamination in both clinical and non-clinical areas.
Finally, Rosemullion assessed personal hygiene and the potential for cross-contamination between patients, colleagues and the environment.
Staff were asked to complete an anonymous ‘Hygiene Self-assessment Questionnaire’ which covered ten areas, including; disinfecting hands; wearing gloves, scrubs with short sleeves and dedicated work shoes, and changing into uniforms when arriving at work.
Amongst clinical staff, there was a 66.75% compliance.
The team then discussed the results, consulted a lab microbiologist and formulated an improvement plan, which included updating the practice cleaning processes (including the cleaning of new touch points), introducing new colleague uniform rules (including changing into uniform upon arrival at work), improving hand hygiene (including providing hand gels for all colleagues) and using sanitising wipes in all office areas.
One month after the policy revisions, swab tests were repeated. They found no bacterial growth in any of the 10 previously swabbed areas.
After two months the colleague questionnaire was run again.
It found clinical colleague compliance over eight personal hygiene indicators had jumped from 66.75% to 92.5% compliance.Abi Redfearn, Senior Veterinary Nurse at Rosemullion, said: “When we opened in 2021, we were keen to monitor our infection control - as part of providing a hospital level of care under the RCVS Practice Standards Scheme.
"With around 100 colleagues and hundreds of patients passing through our doors every week, we are an extremely busy practice – so infection control is paramount in maintaining high clinical standards.“By updating our protocols and taking simple steps - such as providing sanitising materials in high-touch areas – we’ve significantly decreased the risk of environmental contamination.
"Our project is now being used as an example to encourage other practices.”
The course will cover reptiles, pet mammals and captive birds.
Marie says the course will teach you how to approach exotic emergencies confidently, from clinical examination and forming differential diagnoses to medical and surgical approaches for common emergency presentations.
Marie will discuss both clinical management and the stabilisation and care of the critical patient, including fluid therapy, analgesia, contra-indicated medications and hospital cage requirements.
Welfare-focused euthanasia approaches will also be covered for different species.
Tickets cost £300 and the course is open to veterinary surgeons, veterinary nurses and students on a recognised veterinary or nursing course.
Lunch, tea, coffee and biscuits included.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form/
To help veterinary practices engage with pet owners and help them understand the importance of eye health, TVM has produced a range of free educational materials including waiting room displays, informative web pages and social media packs.
The company has also published a page of information at www.tvm-uk.com/eyehealth – where pet owners can find out more about eye problems, how to spot them and learn what can be done about them.
Emma Hancox MRCVS, Veterinary Advisor at TVM said: "It can be easy for owners to miss the signs of problems with their pet’s eyes, but they can be extremely distressing for animals and be a sign of conditions ranging from cataracts and glaucoma through to conjunctivitis - all of which can be painful, and in the worst-case scenario, lead to blindness.
"We hope that National Pet Eye Health Awareness Week will help practices assist owners in understanding the importance of eye health and prevent more serious conditions occurring."
To request your board kit and pet owner leaflets, and download your free social media pack, visit www.tvm-uk.com/eyehealth or contact your Territory Manager.
Following supply issues over the past 12 months, the company has gained regulatory approval to begin supplying Aqupharm through a new manufacturer.
Will Peel, marketing manager at Animalcare said: "We are aware of the challenges vets have faced over the past 12 months due to the shortage in supply, so we have been working hard to manage stock availability, however we are pleased that we are now able to supply the product on demand.
"We’d like to thank all our customers and wholesalers for their support and patience over the past year."
All existing Aqupharm products are available to order except Aqupharm no.3 which has been discontinued due to low market demand.
For product advice, contact: technical@animalcare.co.uk.
For further information or for orders, contact your local Animalcare Territory Manager or email animalcare@animalcare.co.uk.
https://www.aqupharm.co.uk
The Committee has been named after the Supplementary Royal Charter 2015 which broadened the functions of the RCVS and allowed for a more flexible approach when dealing with complaints about professional conduct.
The Charter Case Committee can resolve cases where the conduct of a veterinary surgeon or nurse has fallen far below the level of conduct expected of them, but not so far as to warrant a full, public Disciplinary Committee hearing.
The Committee can deal with such cases without the need for a public hearing and can give veterinary surgeons or nurses either a confidential or a public warning about their future conduct.
A warning issued by the Charter Case Committee does not affect the individual’s registration status or their right to practise.
Eleanor Ferguson, RCVS Registrar, said: “The establishment of the Charter Case Committee plays a vitally important role in balancing our statutory role of upholding professional conduct standards and protecting animal health and welfare and public confidence in the professions, with our mission to become a compassionate regulator.
“The Charter Case Committee Protocol allows for the alternative resolution of certain cases where a veterinary surgeon or veterinary nurse has engaged in behaviour that amounts to serious professional misconduct or has been convicted of an offence, but where it is not in the public interest for the matter to be referred to a hearing of the Disciplinary Committee because it is at the lower end of seriousness.
“The type of cases we envisage being dealt with by the Committee are those where the Code has been breached but where there is no ongoing risk to animal welfare or public confidence, and where the level of insight and personal reflection regarding their conduct is such that it can be resolved without the need for an onerous, stressful and expensive Disciplinary Committee hearing.
"We estimate that the CCC will deal with around 20 such cases per year.
“The most serious cases of professional misconduct will, of course, continue to be referred to Disciplinary Committee hearings.”
https://www.rcvs.org.uk/who-we-are/committees/charter-case-committee.